Seroprevalence of Helicobacter pylori in the adult population of Christchurch: Risk factors and relationship to dyspeptic symptoms and iron studies

New Zealand Medical Journal

Volumn 112, Issue 1093, 1999, Pages 292-295

  Collett, J A ^a   Burt, M J ^c   Frampton, C M A ^c   Yeo, K H J ^c   Chapman, T M ^c   Buttimore, R C ^c   CooK, H B ^c   Chapman, B A ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c Christchurch Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; DYSPEPSIA; EPIDEMIOLOGY; FEMALE; HEALTH; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; MIDDLE AGED; NEW ZEALAND; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SMOKING; SOCIOECONOMICS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DYSPEPSIA; FEMALE; FERRITINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRON; MALE; MIDDLE AGED; NEW ZEALAND; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SMOKING; SOCIOECONOMIC FACTORS; URBAN HEALTH;

EID: 0033551640     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. EUROGAST Study group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-6.
2. Hunt RH. Helicobacter pylori: from theory to practice. Am J Med 1996; 100: ls-64s.
3. Rauws EA, Langenberg W, Houthoff HJ et al. Campylobacter pyloridis-associated chronic active gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33-40.
4. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
5. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 45: 19-22.
6. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
7. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-5.
8. Wotherspoon A, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell. Lancet 1993; 342: 575.
9. Bernersen B, Johnsen R, Bostad L et al. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276-9.
10. Strauss RM, Wang TC, Kelsey PB et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoecopy. Am J Med 1990; 89: 464-9.
11. Rosenstock S, Kay L, Rosenstock C et al. Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997; 41: 169-76.
12. Veldhuyzen van Zanten SJO, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. Can Med Assoc J 1994; 150: 177-86.
13. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1995; 106: 117-83.
14. Axon A, Forman D. Helicobacter gastroduodenitia; a serious infectious disease. BMJ 1997; 314: 1430-1.
15. Milman N, Rosenstock S, Anderson L et al. Serum ferritin, haemoglobin, and Helicobacter pylori infection: A seroepidemiological survey comprising 2794 Danish Adults. Gastroenterology 1998; 115: 268-74.
16. Burt MJ, George PM, Upton JD et al. The significance of haemochromatosis (KFE) gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6.
17. Fawcett JP, Shaw JP, Cockburn M et al. Seroprevalence of Helicobacter pylori in a birth cohort of 21 year old New Zealanders. Eur J Gastroenterol Hepatol 1996; 8: 365-9.
18. Goossens H, Glupczynski Y, Burette A et al. Evaluation of commercially available second generation immunoglobulin G enzyme immunoassay for the detection of Helicobacter pylori infection. J Clin Microbiol 1992; 30: 176-80.
19. Weiss J, Mecca J, DaSilva E. Comparison of PCR and other diagnostic techniques for detection of Helicobacter pylori infection in dyspeptic patients. J Clin Microbiol 1994, 32: 1663-8.
20. Fraser AG, Scragg R, Metcalf P et al. Prevalence of Helicobacter pylon infection in different ethnic groups in New Zealand children and adults. Aust NZ J Med 1996; 25: 646-51.
21. Cullen DJ, Collins BJ, Christiansen KJ et al. When is Helicobacter pylori infection acquired? Gut 1993; 34: 1681-2.
22. Sipponen P, Kosunen TU, Samloff IM et al. Rate of Helicobacter pylori acquisition among Finnish adults. Scand J Gastroenterol 1996; 31: 229-32.
23. Veldhuyzen van Zanten SJO, Pollak PT, Best LM et al. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994; 169: 434-7.
24. Fawcett JP, Shaw JP, Brooke A et al. Seroprevalence of Helicobacter pylori in a longitudinal study of New Zealanders at ages 11 and 21. Aust NZ J Med 1998; 28: 685-9.
25. Brenner H, Rothenbacher D, Bode G et al. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ 1997; 315: 1489-92.
26. Murray LJ, McCrum EE, Evans AE et al. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemio 1997; 26: 880-7.